4//SEC Filing
MARTEK BIOSCIENCES CORP 4
Accession 0001104659-11-009912
CIK 0000892025operating
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 9:56 PM ET
Size
9.4 KB
Accession
0001104659-11-009912
Insider Transaction Report
Form 4
Royal DSM N.V.
10% Owner
Transactions
- Purchase
Common Stock
2011-02-24$31.50/sh+245,302$7,727,013→ 30,042,254 total(indirect: See Footnote) - Purchase
Common Stock
2011-02-22$31.50/sh+32$1,008→ 29,779,952 total(indirect: See Footnote) - Purchase
Common Stock
2011-02-23$31.50/sh+17,000$535,500→ 29,796,952 total(indirect: See Footnote)
Footnotes (1)
- [F1]The Reporting Person is filing this Form 4 on behalf of itself and on behalf of Greenback Acquisition Corporation ("Greenback"), a Delaware corporation and an indirect wholly owned subsidiary of the Reporting Person, with principal executive offices located at 45 Waterview Blvd., Parsippany, NJ 07054. The shares of common stock to which this Form 4 relates were acquired by Greenback during the subsequent offering period of a tender offer for all outstanding shares of common stock of Martek Biosciences Corporation, upon the terms and subject to the conditions set forth in the Offer to Purchase dated January 13, 2011, which was annexed to and filed with the Schedule TO filed by the Reporting Person with the Securities and Exchange Commission on January 13, 2011.
Documents
Issuer
MARTEK BIOSCIENCES CORP
CIK 0000892025
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000892025
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 9:56 PM ET
- Size
- 9.4 KB